Original Research

Page 17

Recently published articles about Original Research

JCP
Abbreviated Suicide Crisis Syndrome Checklist and Decision Making in the ED
Original Research

May 1, 2023

The A-SCS-C had robust clinical utility and reduced clinicians’ reliance on patient-reported suicidal ideation to assess suicide risk in the ED setting.
, , , et al
PCC
Cyberchondria, Quality of Life, and the Moderating Effect of Emotions
Original Research

April 27, 2023

Excessive exposure to copious amount of information, whether of verifiable sources or not, can instigate anxious symptoms in individuals lacking adaptive emotion regulation ability.
, , , et al
PCC
Screening for Bipolar Disorder and Evaluating the RMS
Original Research

April 25, 2023

Health care providers found the Rapid Mood Screener, a new bipolar I disorder screening tool, to be superior to the widely used Mood Disorder Questionnaire in sensitivity/specificity, brevity, practicality,...
, , , et al
JCP
Efficacy of Lumateperone in Bipolar Depression With Mixed Features
Original Research

April 24, 2023

Lumateperone significantly improved depression symptoms, disease severity, and quality of life in patients with bipolar depression with mixed features.
, , , et al
JCP
Pregnancy-Specific Anxiety Tool: Development and Psychometric Evaluation
Original Research

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ April 19, 2023

The Pregnancy-Specific Anxiety Tool contributes new dimensions to the measurement of anxiety in pregnancy. Patients scoring higher than 10 on the PSAT require further assessment.
, , , et al
JCP
LAI Implementation After Schizophrenia Diagnosis
Original Research

April 19, 2023

Although long-acting injectable antipsychotic agents (LAIs) are effective in preventing relapse, their use in first-episode schizophrenia was low, and LAIs were rarely the first therapy for early-phase schizophrenia.
, , , et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe